Red Rock Regeneration Inc.
Clinical trials sponsored by Red Rock Regeneration Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New bone graft could improve foot and ankle surgery outcomes Results expected Nov 2026 (estimated)
-
New bone graft material under scrutiny in 1,000-Patient spine study
Disease control By invitation onlyThis study is tracking 1,000 people who received a bone graft material called Natural Matrix Protein (NMP) during spine surgery for degenerative disc disease. Researchers will monitor bone fusion, pain, and disability over two years to see if NMP is safe and helps the spine heal.…
Sponsor: Red Rock Regeneration Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New bone graft could improve foot and ankle surgery outcomes
Disease control By invitation onlyThis study is testing a new bone graft material called Induce XT in 60 people undergoing foot or ankle fusion surgery. The graft is made from processed human bone and is meant to help the bones heal together. Participants will be followed for 12 months with X-rays, CT scans, and …
Sponsor: Red Rock Regeneration Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC